Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00730678 · ClinicalTrials.gov registry record
Pharmacogenetic Determinants Of Treatment Response In Children
A clinical trial of All Malignancies and Children Being Treated for Catastrophic Illness, sponsored by St. Jude Children's Research Hospital.
- Recruiting
- Registry status
- 8,800
- Enrollment target
- 1
- Study location
NCT00730678: Recruiting study of All Malignancies and Children Being Treated for Catastrophic Illness, sponsored by St. Jude Children's Research Hospital.
NCT00730678 is a study of All Malignancies and Children Being Treated for Catastrophic Illness that is actively recruiting participants, run by St. Jude Children's Research Hospital. The registered enrollment target is 8,800 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00730678, a study of All Malignancies and Children Being Treated for Catastrophic Illness, is actively recruiting participants, sponsored by St. Jude Children's Research Hospital.
- RECRUITING
- Registry status
- 8,800 participants
- Enrollment target
- 1
- Study location
Study Summary
To investigate whether genetic polymorphisms in genes encoding proteins involved in the metabolism or effects of drugs or environmental agents influence the disposition or effects of these xenobiotic substrates. To investigate the nature of heritability and the genetic basis of pharmacogenetic traits by studying family members of individuals with specific genotypes.
Conditions Studied
Study Locations (1)
Tennessee
- St. Jude Children's Research Hospital - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8,800 participants |
| Start Date | 1998-08-17 |
| Est. Completion | 2034-03 |
What NCT00730678 shows while recruiting
NCT00730678 is an observational study that tracks outcomes without assigning an intervention. Its 8,800 participants enrollment target places it among the larger protocols in the corpus.
The record links to 2 conditions, with All Malignancies appearing as the primary indexed condition, and to 0 interventions.
NCT00730678 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT00730678 about?
NCT00730678 is a clinical study titled "Pharmacogenetic Determinants Of Treatment Response In Children". To investigate whether genetic polymorphisms in genes encoding proteins involved in the metabolism or effects of drugs or environmental agents influence the disposition or effects of these xenobiotic substrates. To investigate the nature of heritability and the genetic basis of pharmacogenetic trait...
What is the current status of trial NCT00730678?
This trial is currently recruiting. The enrollment target is 8,800 participants. The study started on 1998-08-17. Estimated completion is 2034-03.
What conditions does trial NCT00730678 study?
This clinical trial studies the following conditions: All Malignancies, Children Being Treated for Catastrophic Illness.
Who is sponsoring clinical trial NCT00730678?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00730678 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05336877 · 8,744 participants
Aveir VR Coverage With Evidence Development Post-Approval Study
- NCT06058234 · 8,680 participants
Medicare Anti-Aβ mAb Coverage With Evidence Development (CED) Study
- NCT05612347 · 8,946 participants · NA
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
- NCT02000089 · 9,000 participants · Phase 3
The Cancer of the Pancreas Screening-5 CAPS5)Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI